<DOC>
	<DOCNO>NCT00163319</DOCNO>
	<brief_summary>The aim study compare safety efficacy ciclesonide versus fluticasone propionate lung function , symptom , use rescue medication , occurrence side effect ( candidiasis , hoarseness ) adult persistent asthma . Ciclesonide inhale twice daily one dose level ; fluticasone propionate inhale twice daily one dose level . The study duration consist baseline period ( 2 week ) treatment period ( 24 week ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Ciclesonide Fluticasone Propionate Adult Patients With Moderate Severe Persistent Asthma ( 18 75 ) ( BY9010/IT-101 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Main Written inform consent History bronchial asthma least 6 month Pretreatment CFCbeclomethasone dipropionate ( CFCBDP ) ≥ 1000 mcg/day equivalent longacting beta agonist ( LABA ) either free fix combination FEV1 ≥ 80 % predict Main Concomitant severe disease disease contraindication use inhaled steroid contraindication use LABAs COPD Smoking ≥10 packyears Pregnancy Intention become pregnant course study Breast feeding Lack safe contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Fluticasone propionate</keyword>
</DOC>